367 (PB-162) - A pilot study to investigate high-sensitivity cardiac troponin I (hscTnI) and high-sensitivity cardiac troponin T (hscTnT) for the prediction of cardiotoxicity in women with breast cancer treated with doxorubicin or trastuzumab

Autor: Utsumi, T., Ishii, J., Naruse, H., Kobayashi, N., Hikichi, M., Ushimado, K.
Zdroj: In European Journal of Cancer April 2018 92 Supplement 3:S104-S104
Databáze: ScienceDirect